Typically, anti-TIF1-γ DM occurs predominantly with skin inflammation, as well as anti-SAE DM, whereas anti-SRP myositis manifests predominantly with muscle weakness and necrotizing myopathy (8). The gene discussed is TRIM33; the disease is dermatomyositis.